Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-29 2:34 pm Purchase |
2024-04-17 | 13G | scPharmaceuticals Inc. SCPH |
LYTTON LAURENCE W | 1,825,234 5.100% |
1,825,234 (New Position) |
Filing History |
| 2024-03-20 1:00 pm Purchase |
2024-02-20 | 13G | Biofrontera Inc. BFRI |
LYTTON LAURENCE W | 508,886 9.990% |
508,886 (New Position) |
Filing History |
| 2024-03-13 1:32 pm Purchase |
2024-02-09 | 13G | Evoke Pharma, Inc. EVOK |
LYTTON LAURENCE W | 71,610 9.990% |
71,610 (New Position) |
Filing History |
| 2024-02-27 2:05 pm Purchase |
2024-02-14 | 13G | Azitra, Inc. AZTR |
LYTTON LAURENCE W | 55,553 5.800% |
55,553 (New Position) |
Filing History |
| 2024-02-14 6:48 pm Sale |
2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
LYTTON LAURENCE W | 11,900 0.100% |
-113,129 (-90.48%) |
Filing History |
| 2024-02-14 3:28 pm Purchase |
2023-12-31 | 13G | Scientific Industries, Inc. SCND |
LYTTON LAURENCE W | 1,083,899 9.990% |
689,220 (+174.63%) |
Filing History |
| 2024-02-14 3:23 pm Purchase |
2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
LYTTON LAURENCE W | 3,280,178 9.990% |
1,395,105 (+74.01%) |
Filing History |
| 2024-02-14 2:42 pm Purchase |
2023-12-31 | 13G | Exagen Inc. XGN |
LYTTON LAURENCE W | 1,153,488 6.800% |
282,307 (+32.41%) |
Filing History |
| 2024-02-14 2:35 pm Purchase |
2023-12-31 | 13G | Stryve Foods, Inc. SNAX |
LYTTON LAURENCE W | 194,780 8.900% |
194,780 (New Position) |
Filing History |
| 2024-02-14 2:27 pm Purchase |
2023-12-31 | 13G | Societal CDMO, Inc. SCTL |
LYTTON LAURENCE W | 10,340,858 9.900% |
3,847,168 (+59.24%) |
Filing History |
| 2024-02-14 2:22 pm Purchase |
2023-12-31 | 13G | Rail Vision Ltd. RVSN |
LYTTON LAURENCE W | 450,000 9.300% |
252,500 (+127.85%) |
Filing History |
| 2024-02-14 2:09 pm Purchase |
2023-12-31 | 13G | RingCentral, Inc. RNG |
LYTTON LAURENCE W | 1,528,157 1.800% |
1,528,157 (New Position) |
Filing History |
| 2024-02-14 2:03 pm Purchase |
2023-12-31 | 13G | Molecular Templates, Inc. MTEM |
LYTTON LAURENCE W | 232,951 4.300% |
232,951 (New Position) |
Filing History |
| 2024-02-14 1:59 pm Sale |
2023-12-31 | 13G | Miromatrix Medical Inc. MIRO |
LYTTON LAURENCE W | 0 0.000% |
-1,380,367 (Position Closed) |
Filing History |
| 2024-02-14 1:49 pm Purchase |
2023-12-31 | 13G | LiqTech International, Inc. LIQT |
LYTTON LAURENCE W | 589,653 9.990% |
589,653 (New Position) |
Filing History |
| 2024-02-14 1:43 pm Sale |
2023-12-31 | 13G | aTyr Pharma, Inc. ATYR |
LYTTON LAURENCE W | 585,013 1.000% |
-3,855,175 (-86.82%) |
Filing History |
| 2024-02-14 1:36 pm Purchase |
2023-12-31 | 13G | Giga-tronics Incorporated GIGA |
LYTTON LAURENCE W | 608,177 9.990% |
4,477 (+0.74%) |
Filing History |
| 2024-02-14 1:31 pm Purchase |
2023-12-31 | 13G | EMCORE Corporation EMKR |
LYTTON LAURENCE W | 778,733 9.990% |
486,406 (+166.39%) |
Filing History |
| 2024-02-14 1:23 pm Sale |
2023-12-31 | 13G | Duos Technologies Group, Inc. DUOT |
LYTTON LAURENCE W | 482,976 6.700% |
-151,049 (-23.82%) |
Filing History |
| 2024-02-14 1:18 pm Unchanged |
2023-12-31 | 13G | Gyre Therapeutics, Inc. GYRE |
LYTTON LAURENCE W | 0 0.000% |
0 (Unchanged) |
Filing History |